Recent Quotes View Full List My Watchlist Create Watchlist Indicators DJI Nasdaq Composite SPX Gold Crude Oil Hydroworld Market Index Markets Stocks ETFs Tools Overview News Currencies International Treasuries Articles published by Processa Pharmaceuticals, Inc. Processa Pharmaceuticals Announces Pricing of $7.0 Million Public Offering January 26, 2024 From Processa Pharmaceuticals, Inc. Via GlobeNewswire Tickers PCSA Processa Pharmaceuticals Announces PCS12852 Successfully Improves the Clinical Symptoms Associated with Gastroparesis in Phase 2A Trial December 14, 2022 From Processa Pharmaceuticals, Inc. Via GlobeNewswire Tickers PCSA Processa Pharmaceuticals Announces Third Quarter Financial Results and Provides Corporate Update November 08, 2022 From Processa Pharmaceuticals, Inc. Via GlobeNewswire Tickers PCSA PCS12852 Improves Gastric Emptying in Gastroparesis Patients November 08, 2022 From Processa Pharmaceuticals, Inc. Via GlobeNewswire Tickers PCSA Processa Pharmaceuticals to Host Conference Call to Discuss Third Quarter 2022 Results and Provide Drug Development Update on November 8, 2022 at 4:30 p.m. EST November 02, 2022 From Processa Pharmaceuticals, Inc. Via GlobeNewswire Tickers PCSA Processa Successfully Identifies Next Generation Capecitabine Dosage Regimens for Phase 2B Trial November 01, 2022 From Processa Pharmaceuticals, Inc. Via GlobeNewswire Tickers PCSA Data & News supplied by www.cloudquote.io Stock quotes supplied by Barchart Quotes delayed at least 20 minutes. By accessing this page, you agree to the following Privacy Policy and Terms and Conditions.